{"id":"https://openalex.org/W1998294553","doi":"https://doi.org/10.1016/j.cellimm.2008.10.002","title":"Murine NKT cells produce Th17 cytokine interleukin-22","display_name":"Murine NKT cells produce Th17 cytokine interleukin-22","publication_year":2008,"publication_date":"2008-11-18","ids":{"openalex":"https://openalex.org/W1998294553","doi":"https://doi.org/10.1016/j.cellimm.2008.10.002","mag":"1998294553","pmid":"https://pubmed.ncbi.nlm.nih.gov/19010461"},"language":"en","primary_location":{"id":"doi:10.1016/j.cellimm.2008.10.002","doi":"https://doi.org/10.1016/j.cellimm.2008.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cellimm.2008.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S193466101","display_name":"Cellular Immunology","issn_l":"0008-8749","issn":["0008-8749","1090-2163"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045673751","display_name":"Megumi Goto","orcid":"https://orcid.org/0000-0002-7079-821X","observed_orcids":["https://orcid.org/0000-0002-7079-821X"]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Megumi Goto","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103392282","display_name":"Masao Murakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Murakawa","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087112392","display_name":"Kumiko Kadoshima-Yamaoka","orcid":"https://orcid.org/0000-0003-1951-918X","observed_orcids":["https://orcid.org/0000-0003-1951-918X"]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kumiko Kadoshima-Yamaoka","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102956730","display_name":"Yoshitaka Tanaka","orcid":"https://orcid.org/0000-0001-9824-9653","observed_orcids":["https://orcid.org/0000-0001-9824-9653"]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitaka Tanaka","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020523235","display_name":"Kazuhiro Nagahira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiro Nagahira","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111652352","display_name":"Yoshiaki Fukuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264332","display_name":"Asubio Pharma Co., Ltd. (Japan)","ror":"https://ror.org/01m1rez02","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405264332"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshiaki Fukuda","raw_affiliation_strings":["Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Research Laboratories, Asubio Pharma Co., Limited, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4405264332"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066413780","display_name":"Takashi Nishimura","orcid":"https://orcid.org/0000-0002-5517-8303","observed_orcids":["https://orcid.org/0000-0002-5517-8303"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I4405286760","display_name":"Institute for Genetic Medicine, Hokkaido University","ror":"https://ror.org/0319h6x77","country_code":"JP","type":"facility","lineage":["https://openalex.org/I205349734","https://openalex.org/I4405286760"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Nishimura","raw_affiliation_strings":["Division of Immunoregulation; Section of Disease Control; Institute for Genetic Medicine; Hokkaido University; Sapporo; Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Immunoregulation; Section of Disease Control; Institute for Genetic Medicine; Hokkaido University; Sapporo; Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I4405286760"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111652352"],"corresponding_institution_ids":["https://openalex.org/I4405264332"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":4.1504,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.94677905,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"254","issue":"2","first_page":"81","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.23489999771118164,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nkt-cells","display_name":"NKT cells","score":0.8799999952316284},{"id":"https://openalex.org/keywords/il-22","display_name":"IL-22","score":0.9779999852180481},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.9860000014305115},{"id":"https://openalex.org/keywords/th17-cytokines","display_name":"Th17 cytokines","score":0.9850000143051147},{"id":"https://openalex.org/keywords/alpha-galactosylceramide","display_name":"alpha-galactosylceramide","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cd3-cd28-costimulation","display_name":"anti-CD3/CD28 stimulation","score":0.9610000252723694},{"id":"https://openalex.org/keywords/splenocytes","display_name":"splenocytes","score":0.6549999713897705},{"id":"https://openalex.org/keywords/cytokine-regulation","display_name":"cytokine regulation","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.8282167911529541},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6070898175239563},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.596194863319397},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5496585369110107},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5232059955596924},{"id":"https://openalex.org/C98119934","wikidata":"https://www.wikidata.org/wiki/Q14907167","display_name":"Interleukin 15","level":4,"score":0.5193784832954407},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.47376683354377747},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.4702312648296356},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.4163219928741455},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4020504653453827},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.33518826961517334},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33386069536209106},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.3166620433330536},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000097043","descriptor_name":"Interleukin-22","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006377","descriptor_name":"T-Lymphocytes, Helper-Inducer","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055611","descriptor_name":"Natural Killer T-Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055611","descriptor_name":"Natural Killer T-Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055611","descriptor_name":"Natural Killer T-Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.cellimm.2008.10.002","doi":"https://doi.org/10.1016/j.cellimm.2008.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cellimm.2008.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S193466101","display_name":"Cellular Immunology","issn_l":"0008-8749","issn":["0008-8749","1090-2163"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular Immunology","raw_type":"journal-article"},{"id":"pmid:19010461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19010461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1262230077","https://openalex.org/W1507781793","https://openalex.org/W1526574246","https://openalex.org/W1554022361","https://openalex.org/W1576903429","https://openalex.org/W1979103098","https://openalex.org/W1987389251","https://openalex.org/W1994260839","https://openalex.org/W2003747312","https://openalex.org/W2007121925","https://openalex.org/W2012077729","https://openalex.org/W2034885002","https://openalex.org/W2039734292","https://openalex.org/W2055039856","https://openalex.org/W2071127998","https://openalex.org/W2074753880","https://openalex.org/W2082159115","https://openalex.org/W2091845172","https://openalex.org/W2097849141","https://openalex.org/W2133657961","https://openalex.org/W2138453840","https://openalex.org/W2139008734","https://openalex.org/W2139121810","https://openalex.org/W2143076511","https://openalex.org/W2146333550","https://openalex.org/W2163992046","https://openalex.org/W4248035038","https://openalex.org/W6668760010"],"related_works":["https://openalex.org/W2293471345","https://openalex.org/W1588732320","https://openalex.org/W2014587453","https://openalex.org/W1566974294","https://openalex.org/W2074612105","https://openalex.org/W1972536818","https://openalex.org/W2163992046","https://openalex.org/W4313379151","https://openalex.org/W2323391854","https://openalex.org/W1555287564"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}